TG Therapeutics (NASDAQ:TGTX – Free Report) had its target price increased by HC Wainwright from $49.00 to $55.00 in a report ...

On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $28.81 which represents a slight increase of $0.91 or 3.26% from the prior close of $27.9. The stock ...

TG Therapeutics' Q3 earnings missed EPS expectations despite Briumvi's revenue growth. See why TGTX stock is a Buy.

TG Therapeutics, Inc. reported a modest Q3 beat and raised the full-year net sales guidance range for Briumvi by $7.5 million ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $40.4, a high estimate of $50.00, ...

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on TG Therapeutics (TGTX – Research Report), with a price ...

TD Cowen analyst Tara Bancroft maintained a Buy rating on TG Therapeutics (TGTX – Research Report) today and set a price target of ...

During the third quarter, TG Therapeutics boosted Briumvi's market penetration, driving U.S. net revenue up by over 230% year ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

On a per-share basis, the Morrisville, New York-based company said it had profit of 2 cents. The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks ...

Super Micro Computer is due to hold a business-update call after Tuesday's closing bell on the heels of heavy selling pressure for its stock. Shares are down nearly 50% since Super Micro's ...